Form 4 Filing for Abeona Therapeutics Inc.

Mark Alvino, a director at Abeona Therapeutics Inc., reported the sale of 6500 shares of common stock on May 22, 2026. The shares were sold at a weighted average price of $5.4558, with individual transactions ranging from $5.44 to $5.47. Following these transactions, Mr. Alvino owns 77,565 shares of the company's common stock. This filing is made on Form 4, indicating a change in beneficial ownership.